Leukemia Clinical Trials in San Francisco

Showing 301-320 of 495 trials

Improving Palliative Care Access Through Technology

NCT04969484

This project will focus on developing, optimizing and pilot-testing a multi-component Improving Access Through Technology (ImPAcTT) intervention that leverages existing telehealth technologies to provide staff education; family outreach, engagement and support; care coordination; and resident symptom management and facilitation of goals-of-care discussion.

TelehealthPalliative Care

University of Utah81 participantsStarted Feb 2018

San Francisco, California, United States • Salt Lake City, Utah, United States

COMPLETEDPHASE3< 1 mile

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

NCT01492101

The study is designed as an open-label, randomized, parallel, two arm, multicenter, international Phase 3 study in patients with recurrent or metastatic breast cancer previously treated with cytotoxic chemotherapy regimens. The primary study objective is to compare overall survival of patients who receive NKTR-102 given once every 21 days to patients who receive treatment of Physician's Choice selected from a list of seven single-agent intravenous therapies.

Locally Recurrent Breast CancerMetastatic Breast Cancer

Nektar Therapeutics852 participantsStarted Dec 2011

Flagstaff, Arizona, United States • Burbank, California, United States • Los Angeles, California, United States +150 more locations

Improving Palliative Care Access Through Technology

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Leukemia Trials in Other Cities

A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma

A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients

Selecting a Favorable KIR Donor in Unrelated HCT for AML

Other Conditions in San Francisco